Results 201 to 210 of about 2,257,217 (287)
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Understanding Patients' Preferences for Discussing Sexuality After Surgery-A Qualitative Study of Sexuality and Body Image in Women with Ovarian Cancer. [PDF]
Stöckl JR +3 more
europepmc +1 more source
Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li +10 more
wiley +1 more source
The role of leadership identity in business and public sectors: a content analysis approach. [PDF]
Engin S, Kasap F.
europepmc +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Role of Spirituality as a Coping Method for Psychological Distress in People Living with HIV/AIDS. [PDF]
Joseph EM, Abraham S, Lionel J.
europepmc +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Strategic equity compensation: A delphi-AHP approach to industry-specific governance design for RSUs. [PDF]
Park WA, Sernova E, Park CY.
europepmc +1 more source
Differentiated trust: navigating credibility landscapes in community-engaged research. [PDF]
Arxer SL.
europepmc +1 more source

